Viracta Therapeutics Inc. buy BiotechBee
Start price
24.06.23
/
60%
€1.43
Target price
31.12.25
€3.00
Performance (%)
-43.01%
End price
15.04.24
€0.82
Summary
This prediction ended on 15.04.24 with a price of €0.82. The BUY prediction by BiotechBee for Viracta Therapeutics Inc. performed very badly with a performance of -43.01%. BiotechBee has 60% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Viracta Therapeutics Inc. | -7.463% | -7.463% | -78.983% |
iShares Core DAX® | 1.665% | 0.362% | 17.556% |
iShares Nasdaq 100 | -0.475% | -3.195% | 26.812% |
iShares Nikkei 225® | 2.620% | 1.174% | 17.273% |
iShares S&P 500 | -0.091% | -1.597% | 24.739% |
According to BiotechBee what are the pros and cons of Viracta Therapeutics Inc. for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Sunesis Pharmaceuticals diskutieren
Buy mit Kursziel 3,0
In the thread Trading Sunesis Pharmaceuticals
Buy beendet
Stopped prediction by BiotechBee for Viracta Therapeutics Inc.
Viracta Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.25
15.04.24
15.04.24
€3.00
31.10.25
31.10.25
-
15.04.24
15.04.24
Could be very worthwhile Investment >20% year